These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6531941)

  • 1. A species difference in the presystemic metabolism of carbazeran in dog and man.
    Kaye B; Offerman JL; Reid JL; Elliott HL; Hillis WS
    Xenobiotica; 1984 Dec; 14(12):935-45. PubMed ID: 6531941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative metabolism of carbazeran in vitro by liver cytosol of baboon and man.
    Kaye B; Rance DJ; Waring L
    Xenobiotica; 1985 Mar; 15(3):237-42. PubMed ID: 4024658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
    Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD
    Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of carbazeran in guinea pig: effect of hydralazine pretreatment.
    Critchley DJ; Rance DJ; Beedham C
    Xenobiotica; 1994 Jan; 24(1):37-47. PubMed ID: 8165820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of remoxipride in different species. Species differences in metabolism.
    Widman M; Nilsson LB; Bryske B; Lundström J
    Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and disposition of 14C-granisetron in rat, dog and man after intravenous and oral dosing.
    Clarke SE; Austin NE; Bloomer JC; Haddock RE; Higham FC; Hollis FJ; Nash M; Shardlow PC; Tasker TC; Woods FR
    Xenobiotica; 1994 Nov; 24(11):1119-31. PubMed ID: 7701853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
    Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
    Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on pharmacokinetics and biotransformation of reproterol in animal and man (author's transl)].
    Niebch G; Obermeier K; Vergin H; Thiemer K
    Arzneimittelforschung; 1977; 27(12):37-45. PubMed ID: 576829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolism of methiothepin in the rat, dog and man].
    Eschenhof E; Meister W; Oesterhelt G; Vetter W
    Arzneimittelforschung; 1976 Feb; 26(2):262-71. PubMed ID: 947211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
    Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
    Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biotransformation of tramadol in man and animal (author's transl)].
    Lintz W; Erlaçin S; Frankus E; Uragg H
    Arzneimittelforschung; 1981; 31(11):1932-43. PubMed ID: 7198474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative metabolism of hydrocodone in man, rat, guinea pig, rabbit, and dog.
    Cone EJ; Darwin WD; Gorodetzky CW; Tan T
    Drug Metab Dispos; 1978; 6(4):488-93. PubMed ID: 28931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs.
    Beconi MG; Reed JR; Teffera Y; Xia YQ; Kochansky CJ; Liu DQ; Xu S; Elmore CS; Ciccotto S; Hora DF; Stearns RA; Vincent SH
    Drug Metab Dispos; 2007 Apr; 35(4):525-32. PubMed ID: 17220241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biotransformation of phenylbutazone (Butazolidin).
    Faigle JW; Dieterle W
    J Int Med Res; 1977; 5 Suppl 2():2-14. PubMed ID: 410685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presystemic elimination of the beta-blocker pafenolol in the rat after oral and intraperitoneal administration and identification of a main metabolite in both rats and humans.
    Lennernäs H; Renberg L; Hoffmann KJ; Regårdh CG
    Drug Metab Dispos; 1993; 21(3):435-40. PubMed ID: 8100498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of mazindol. III. Comparison of metabolism in rat, dog, and man.
    Dugger HA; Madrid VO; Talbot KC; Coombs RA; Orwig BA
    Drug Metab Dispos; 1979; 7(3):132-7. PubMed ID: 38082
    [No Abstract]   [Full Text] [Related]  

  • 20. Modipafant, a new PAF antagonist: pharmacokinetics and disposition in rat, dog and man.
    Jezequel SG; Uden S; Wastall P
    Xenobiotica; 1996 Sep; 26(9):963-75. PubMed ID: 8893043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.